Literature DB >> 16456014

Priming of glomerular mesangial cells by activated macrophages causes blunted responses to proinflammatory stimuli.

Kunihiro Hayakawa1, Yiman Meng, Nobuhiko Hiramatsu, Ayumi Kasai, Kozue Yamauchi, Jian Yao, Masanori Kitamura.   

Abstract

Macrophage-mesangial cell interaction plays a crucial role in the pathogenesis of glomerulonephritis. Activated macrophages trigger mesangial cells to express an array of inflammation-associated genes via activation of NF-kappaB and AP-1. However, this inflammatory response is often transient and subsides spontaneously. We found that mesangial cells activated by bystander macrophages showed blunted responses of NF-kappaB to subsequent macrophage exposure. It was associated with sustained levels of IkappaBbeta, but not IkappaBalpha. The tolerance observed was reversible and reproduced by conditioned media from activated macrophages (macrophage-conditioned medium (MphiCM)). In vivo priming of mesangial cells by activated glomerular macrophages also caused the tolerance of mesangial cells. The macrophage-derived tolerance inducers were heat-labile, and multiple molecules were involved. Among inflammatory cytokines produced by macrophages, TNF-alpha and IL-1beta were able to induce mesangial cell tolerance dose-dependently. The mesangial cell tolerance was also observed in activation of the MAPK-AP-1 pathway; i.e., phosphorylation of ERK, JNK, and p38 MAPK by macrophages was blunted when the cells were pre-exposed to MphiCM. Induction of c-fos and c-jun was also abrogated in mesangial cells pre-exposed to MphiCM, and the suppression was attenuated by blockade of MAPK activation during the first exposure to MphiCM. These data elucidated that mesangial cells, once exposed to macrophages, become insensitive to subsequent activation by macrophages and proinflammatory stimuli. This self defense of glomerular cells may play a role in the resolution of macrophage-mediated, acute glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16456014     DOI: 10.4049/jimmunol.176.4.2529

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response.

Authors:  Hiroaki Yamazaki; Nobuhiko Hiramatsu; Kunihiro Hayakawa; Yasuhiro Tagawa; Maro Okamura; Ryouji Ogata; Tao Huang; Shotaro Nakajima; Jian Yao; Adrienne W Paton; James C Paton; Masanori Kitamura
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

2.  mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway.

Authors:  H Kato; S Nakajima; Y Saito; S Takahashi; R Katoh; M Kitamura
Journal:  Cell Death Differ       Date:  2011-07-22       Impact factor: 15.828

3.  ER stress depresses NF-kappaB activation in mesangial cells through preferential induction of C/EBP beta.

Authors:  Kunihiro Hayakawa; Shotaro Nakajima; Nobuhiko Hiramatsu; Maro Okamura; Tao Huang; Yukinori Saito; Yasuhiro Tagawa; Minori Tamai; Shuhei Takahashi; Jian Yao; Masanori Kitamura
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

4.  Unique regulatory properties of mesangial cells are genetically determined in the rat.

Authors:  Ping-Chin Lai; Ling-Yin Chiu; Prashant Srivastava; Cristina Trento; Francesco Dazzi; Enrico Petretto; H Terence Cook; Jacques Behmoaras
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

5.  Inhibition of PTP1B Promotes M2 Polarization via MicroRNA-26a/MKP1 Signaling Pathway in Murine Macrophages.

Authors:  Xiaolong Xu; Xuerui Wang; Yuhong Guo; Yunjing Bai; Shasha He; Ning Wang; Yan Lin; Marc Fisher; Qingquan Liu; Yongming Yao
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

6.  Macrophage Infiltration Induces Gastric Cancer Invasiveness by Activating the β-Catenin Pathway.

Authors:  Ming-Hsun Wu; Wei-Jiunn Lee; Kuo-Tai Hua; Min-Liang Kuo; Ming-Tsan Lin
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.